NCT01458366 2025-04-30Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and EtoposideThomas Jefferson UniversityPhase 1/2 Completed38 enrolled 17 charts
NCT00588094 2015-12-04Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHLMemorial Sloan Kettering Cancer CenterPhase 2 Completed20 enrolled 6 charts